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Magnesium plays a role in calcium metabolism and hypomagnesaemia can lead
to hypocalcaemia.1 Recently it has been recognised that prolonged amino-
glycoside therapy can cause hypomagnesaemia.2 3 We have recently observed
tetany associated with low serum levels of both calcium and magnesium in a
patient receiving gentamicin, which resolved when the gentamicin was stopped
and the serum magnesium was corrected.
CASE HISTORY
A 21 -year-old male with a congenital ventricular septal defect was admitted with
a ten -day history of rigors, malaise and anorexia. Three out of six blood cultures
grew Staphylococcus aureus. A diagnosis of infective endocarditis was made
and treatment with intravenous flucloxacillin and gentamicin was begun.
Frequent peak and trough gentamicin levels were maintained within the thera -
peutic range. Eighteen days after treatment commenced, the pyrexia recurred
and flucloxacillin was replaced by vancomycin. Three days later, he developed an
allergic drug rash, and the vancomycin was changed to fusidic acid. Antibiotics
were administered for a total of 56 days (Table).
Fifty-one days after treatment commenced, he complained of tingling around
the lips and developed carpopedal spasm. The tetany responded to 30ml
10% calcium gluconate (6-69mmol). The uncorrected serum calcium was
1-36mmol/I (2-10-2-50) and the serum magnesium was 0-39mmol/1
(0-7-1-03). Serum parathormone was 0-22pg/l which is inappropriately
low for the serum calcium. Serum urea was 7-7mmol/I (3-3-8-8), creatinine
154mmol/1 (40-110), and albumin 39g/l (30-45).
A magnesium load of 30mmol/1 magnesium sulphate in 250ml of 5% dextrose
was given intravenously over four hours, and urine collected over 24 hours
for magnesium excretion. He excreted 68% of the total magnesium load in 24
hours (normal less than 50%) which shows excessive renal magnesium loss and
excludes non-renal causes of magnesium deficiency.1' 4The calculation of the
magnesium deficit is empirical as 99% of total body magnesium is intracellular
and so serum magnesium does not accurately reflect total body magnesium. The
deficit required to produce hypomagnesaemia is 0-5-1 mmol/kg of body
weight. In our patient the deficit was 50mmol.
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TABLE
Gentamicin and otherdrug therapies in relation toserum calciumandmagnesium
Serum Ca Serum Mg
Day Drugs mmol/l mmol/l
1 Gentamicin, flucloxacillin 2411 0-84
18 Gentamicin, vancomycin 2-19 0*89
21 Drug rash 2-11 0 71
28 Gentamicin, fusidic acid 2412 0-74
35 Gentamicin, fusidic acid 2-11 0.79
46 Gentamicin, fusidic acid 1-96 0*62
48 Gentamicin, fusidic acid 1-61 0-66
51 Gentamicin, fusidic acid 1*36 0.45
(onset of tetany, gentamicin stopped)
52 Magnesium sulphate infusion 1-63 0-98
55 Magnesium sulphate infusion 1P62 0-86
56 Magnesium glycerophosphate orally 1-71 0-87
80 Magnesium glycerophosphate orally 2-29 0*79
However, to replace this deficit, excess magnesium had to be administered as our
patient only retained 32% of a magnesium load. Therefore he required at least
150mmol magnesium inordertoretain 50mmol magnesium. Atotalof210mmol
magnesium sulphate was given intravenously over five days. No further tetany
occurred and calcium supplements were not required. He was then given oral
magnesium glycerophosphate for three months.
DISCUSSION
Magnesium deficiency can be the result of decreased intake (prolonged intra-
venous feeding, chronic alcoholism, intestinal malabsorption), increased non-
renal loss (chronic diarrhoea, biliary fistula) or increased renal loss (diuretic
therapy, renal tubular acidosis, drug-induced tubular injury [cisplatin, ampho-
tericin, gentamicin], hyperaldosteronism).
In our patient, the evidence pointed to increased renal loss as a cause of
magnesium deficiency as there was excessive renal excretion of magnesium,
despite a low serum magnesium. The normal response of the kidney to hypo-
magnesaemia is to reabsorb the ion in the renal tubules. He had been on a diuretic
from admission but this was later discontinued after a drug rash developed.
Magnesium levels during administration of the diuretic were within the normal
range. A small number of case reports show that prolonged aminoglycoside
therapy is thought to cause a renal tubular leak of magnesium assessed by the
renal response to a magnesium load.2'3,5 Renal function may otherwise be
entirely normal and toxic levels of the drug do not have to occur.
Hypomagnesaemia can cause hypocalcaemia by inhibiting the secretion of
parathormone and by causing skeletal and renal resistance to the effects of
parathormone.I Tetany in these patients will respond to intravenous magnesium
sulphate and may not respond to intravenous calcium.2 In our patient there was
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an initial temporary response to intravenous calcium, but his hypocalcaemia was
finally corrected by replacing magnesium, and oral calcium supplements were
not required. Itis suggested thatall patientson prolonged aminoglycoside therapy
should have regular measurements of serum calcium and magnesium. The renal
tubular leak can persist up to three months and therefore prolonged oral
magnesium therapy may be required.
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BOOK REVIEW
Insurance handbook for the medical office. By Marilyn Takahashi Fordney. 3rd ed. (pp 528. lllus,
figs. £18.00, paperback). Philadelphia: Saunders, 1989.
I approached this book with interest because American-type medical insurance practices are rapidly
approaching our shores. My curiosity was even further whetted on reading through the table of
contents when I found Chapters 2 and 3 related to Coding for professional services and Diagnostic
coding and Chapter 4 dealing with Diagnosis related groups (DRGs). In these there is an excellent
'Idiot's guide' to the coding systems ICD-9 and ICD-9-CM, and a very full and general description
of the rationale and working of DRGs.
These three chapters are, however, only 65 pages in a book of a total of 515, the remainder of which
comprise a detailed and comprehensive exposition and explanation forthe medical assistant, account's
clerk and assistant treasurer in the North American medical domain. For them I am sure this is an
update, easy to read and understand, which will enhance the skills necessary to handle medical
insurance claims by physicians, surgeons and other doctors and their supporting staffs. It certainly will
live up to its claim to help increase accuracy and efficiency on thejob and thereby bring more revenue
into the medical office. Nevertheless, interesting as it may be, it is not yet a required or recommended
text for the British or Irish reader. GAM
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